Search details
1.
Daratumumab Monotherapy for Heavily Pre-treated and Refractory Myeloma: Results from a UK Multicentre Real World Cohort.
J Oncol Pharm Pract
; 29(2): 299-304, 2023 Mar.
Article
in English
| MEDLINE | ID: mdl-34939868
2.
Impaired humoral and cellular response to primary COVID-19 vaccination in patients less than 2 years after allogeneic bone marrow transplant.
Br J Haematol
; 198(4): 668-679, 2022 08.
Article
in English
| MEDLINE | ID: mdl-35655410
3.
Myeloma clinical outcomes following the first wave of COVID-19: results from the Thames Valley Cancer Alliance (UK).
Br J Haematol
; 192(6): e136-e139, 2021 03.
Article
in English
| MEDLINE | ID: mdl-33326594
4.
Beta thalassemia major and Noonan syndrome - Two genetic disorders manifest in the blood film.
Am J Hematol
; 95(9): 1113-1114, 2020 09.
Article
in English
| MEDLINE | ID: mdl-32112432
5.
FTLD-ALS of TDP-43 type and SCA2 in a family with a full ataxin-2 polyglutamine expansion.
Acta Neuropathol
; 128(4): 597-604, 2014 Oct.
Article
in English
| MEDLINE | ID: mdl-24718895
6.
Panobinostat in combination with bortezomib and dexamethasone in multiply relapsed and refractory myeloma; UK routine care cohort.
PLoS One
; 17(7): e0270854, 2022.
Article
in English
| MEDLINE | ID: mdl-35797277
7.
Fractures are common within 18 months following first-line R-CHOP in older patients with diffuse large B-cell lymphoma.
Blood Adv
; 4(18): 4337-4346, 2020 09 22.
Article
in English
| MEDLINE | ID: mdl-32915975
8.
Treatment stratification of respiratory syncytial virus infection in allogeneic stem cell transplantation.
J Infect
; 78(6): 461-467, 2019 06.
Article
in English
| MEDLINE | ID: mdl-30965067
Results
1 -
8
de 8
1
Next >
>>